美国肾臟去神经导管市场规模、份额和趋势分析报告：按产品、最终用途和细分市场预测，2025 年至 2033 年

美国肾臟去神经导管市场摘要

2025 年美国肾臟去神经导管市场价值估计为 2,320 万美元，预计到 2033 年将达到 1.827 亿美元，2025 年至 2033 年的复合年增长率为 29.43%。推动这一增长的因素包括高血压盛行率的上升和人们对药物治疗局限性的认识的提高、越来越多的临床证据支持肾臟核准的安全性和有效性，以及 FDA 最近批准等有利的监管发展，进一步加速了市场采用。

根据美国国家卫生统计中心和国家健康与营养检查调查2024年10月发布的数据，2021年8月至2023年8月期间，美国成年人高血压患病率在18-39岁人群中上升至23.4%，在40-59岁人群中上升至52.5%，在60岁及以上人群中达到71.6%。

高血压的高发生率是美国肾臟去神经导管产业的主要驱动力之一。此外，越来越多的患者患有抗治疗性高血压，这种高血压对多种抗高血压药物反应不佳。这种普遍存在的疾病负担使得临床对替代治疗性介入（例如肾臟去神经导管）产生了强烈的需求，这种干预措施提供了一种非药物的长期血压控制方法。随着认知度和诊断率的提高，预计适合接受肾臟去神经导管手术的患者群体将会增加，从而进一步推动市场需求。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国肾臟去神经导管市场变数、趋势与范围

• 市场体系展望
  • 补贴市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
  • 市场机会分析
  • 市场问题分析
• 美国肾臟去神经导管市场分析工具
  • 产业分析-波特五力分析
  • PESTEL分析

第四章美国肾臟去神经导管市场：产品估计与趋势分析

• 细分仪表板
• 美国肾臟去神经导管市场的产品差异分析
• 美国肾臟去神经导管市场规模及趋势分析（依产品，2025-2033）
• 射频（RF）消融导管
• 超音波消融导管

第五章美国肾臟去神经导管市场：最终用途估计和趋势分析

• 细分仪表板
• 美国肾臟去神经导管市场的最终用途差异分析
• 2025-2033年美国肾去神经导管市场规模及趋势分析（依最终用途）
• 医院
• 其他的

第六章 竞争态势

• 市场参与企业分类
• 主要企业简介
  • Recor Medical, Inc.（Otsuka Medical Devices Co., Ltd.）
  • Medtronic
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • EnligHTN, St. Jude Medical（Abbott Laboratories）
  • Ablative Solutions, Inc.

U.S. Renal Denervation Catheter Market Summary

The U.S. renal denervation catheter market size was estimated at USD 23.20 million in 2025 and is projected to reach USD 182.70 million by 2033, growing at a CAGR of 29.43% from 2025 to 2033. The growth is driven by the rising prevalence of hypertension and growing awareness about the limitations of pharmacological treatments, increasing clinical evidence supporting the safety and efficacy of renal denervation, and favorable regulatory advancements, such as the recent FDA approval, are further accelerating market adoption.

According to data released by the National Center for Health Statistics and the National Health and Nutrition Examination Survey in October 2024, the prevalence of hypertension among U.S. adults was 23.4% for those aged 18-39, rising to 52.5% for individuals aged 40-59, and reaching 71.6% for those aged 60 and older during the period from August 2021 to August 2023.

The high prevalence of hypertension is one of the primary drivers for the U.S. renal denervation catheter industry. In addition, a growing subset of patients suffers from treatment-resistant hypertension, which does not respond adequately to multiple antihypertensive medications. This widespread burden of disease creates a strong clinical need for alternative therapeutic interventions, such as renal denervation, which offers a non-pharmacological approach to long-term blood pressure control. As awareness and diagnosis rates improve, the eligible patient pool for RDN procedures is expected to expand, further propelling market demand.

U.S. Renal Denervation Catheter Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2025 to 2033. For this study, Grand View Research has segmented the U.S. renal denervation catheter market report based on product and end use:

• Product Outlook (Revenue, USD Million, 2025 - 2033)
• Radiofrequency (RF) Ablation Catheters
• Ultrasound Ablation Catheters
• End Use Outlook (Revenue, USD Million, 2025 - 2033)
• Hospitals
• Other

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
  • 1.5.5. Information Analysis
  • 1.5.6. Data Analysis Models
• 1.6. Market Formulation & Data Visualization
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. List of Secondary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Renal Denervation Catheter Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of hypertension as a leading cause of cardiovascular disease
    • 3.2.1.2. Growing regulatory approvals
    • 3.2.1.3. Increasing awareness about hypertension management market restraint analysis
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Potential adverse events and complications associated with renal denervation catheters
    • 3.2.2.2. Shortage of cardiologists
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Growing clinical trials for renal denervation catheters
    • 3.2.3.2. Improving reimbursement for renal denervation catheters
    • 3.2.3.3. Strategic investments for renal denervation product portfolio expansion
    • 3.2.3.4. Advancing multielectrode RDN catheters with dual access capabilities
  • 3.2.4. Market Challenges Analysis
    • 3.2.4.1. Stringent regulations
• 3.3. U.S. Renal Denervation Catheter Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Renal Denervation Catheter Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Renal Denervation Catheter Market Product Movement Analysis
• 4.3. U.S. Renal Denervation Catheter Market Size & Trend Analysis, by Product, 2025 to 2033 (USD Million)
• 4.4. Radiofrequency (RF) Ablation Catheters
  • 4.4.1. Radiofrequency (RF) Ablation Catheters Market Revenue Estimates and Forecasts, 2025 - 2033 (USD Million)
• 4.5. Ultrasound Ablation Catheters
  • 4.5.1. Ultrasound Ablation Catheters U.S. Renal Denervation Catheter Market Revenue Estimates and Forecasts, 2025 - 2033 (USD Million)

Chapter 5. U.S. Renal Denervation Catheter Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Renal Denervation Catheter Market End Use Movement Analysis
• 5.3. U.S. Renal Denervation Catheter Market Size & Trend Analysis, by End Use, 2025 to 2033 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals U.S. Renal Denervation Catheter Market Revenue Estimates and Forecasts, 2025 - 2033 (USD Million)
• 5.5. Other
  • 5.5.1. Other U.S. Renal Denervation Catheter Market Revenue Estimates and Forecasts, 2025 - 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Market Participant Categorization
• 6.2. Key Company Profiles
  • 6.2.1. Recor Medical, Inc. (Otsuka Medical Devices Co., Ltd.)
    • 6.2.1.1. Company Overview
    • 6.2.1.2. Financial Performance
    • 6.2.1.3. Product Benchmarking
    • 6.2.1.4. Strategic Initiatives
  • 6.2.2. Medtronic
    • 6.2.2.1. Company Overview
    • 6.2.2.2. Financial Performance
    • 6.2.2.3. Product Benchmarking
    • 6.2.2.4. Strategic Initiatives
  • 6.2.3. Boston Scientific Corporation
    • 6.2.3.1. Company Overview
    • 6.2.3.2. Financial Performance
    • 6.2.3.3. Product Benchmarking
    • 6.2.3.4. Strategic Initiatives
  • 6.2.4. MicroPort Scientific Corporation
    • 6.2.4.1. Company Overview
    • 6.2.4.2. Financial Performance
    • 6.2.4.3. Product Benchmarking
    • 6.2.4.4. Strategic Initiatives
  • 6.2.5. EnligHTN, St. Jude Medical (Abbott Laboratories)
    • 6.2.5.1. Company Overview
    • 6.2.5.2. Financial Performance
    • 6.2.5.3. Product Benchmarking
    • 6.2.5.4. Strategic Initiatives
  • 6.2.6. Ablative Solutions, Inc.
    • 6.2.6.1. Company Overview
    • 6.2.6.2. Financial Performance
    • 6.2.6.3. Product Benchmarking
    • 6.2.6.4. Strategic Initiatives

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. U.S. Renal Denervation Catheter Market, by Product, 2025 - 2033 (USD Million)
• Table 4. U.S. Renal Denervation Catheter Market, by End Use, 2025 - 2033 (USD Million)
• Table 5. Participant's Overview
• Table 6. Financial Performance
• Table 7. Product Benchmarking
• Table 8. Strategic Initiatives

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Renal Denervation Catheter Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 11 Porter's Five Forces Analysis
• Fig. 12 Regional Marketplace: Key Takeaways
• Fig. 13 U.S. Renal Denervation Catheter Market, for Product, 2025 - 2033 (USD Million)
• Fig. 14 U.S. Renal Denervation Catheter Market, for Radiofrequency (RF) Ablation Catheters, 2025 - 2033 (USD Million)
• Fig. 15 U.S. Renal Denervation Catheter Market, for Ultrasound Ablation Catheters, 2025 - 2033 (USD Million)
• Fig. 16 U.S. Renal Denervation Catheter Market, for End Use, 2025 - 2033 (USD Million)
• Fig. 17 U.S. Renal Denervation Catheter Market, for Hospitals, 2025 - 2033 (USD Million)
• Fig. 18 U.S. Renal Denervation Catheter Market, for Other, 2025 - 2033 (USD Million)